JP2022538886A5 - - Google Patents

Info

Publication number
JP2022538886A5
JP2022538886A5 JP2021577915A JP2021577915A JP2022538886A5 JP 2022538886 A5 JP2022538886 A5 JP 2022538886A5 JP 2021577915 A JP2021577915 A JP 2021577915A JP 2021577915 A JP2021577915 A JP 2021577915A JP 2022538886 A5 JP2022538886 A5 JP 2022538886A5
Authority
JP
Japan
Application number
JP2021577915A
Other languages
Japanese (ja)
Other versions
JPWO2021003149A5 (https=
JP2022538886A (ja
JP7744248B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/040282 external-priority patent/WO2021003149A1/en
Publication of JP2022538886A publication Critical patent/JP2022538886A/ja
Publication of JP2022538886A5 publication Critical patent/JP2022538886A5/ja
Publication of JPWO2021003149A5 publication Critical patent/JPWO2021003149A5/ja
Application granted granted Critical
Publication of JP7744248B2 publication Critical patent/JP7744248B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577915A 2019-07-01 2020-06-30 トランスジェニック哺乳動物およびその使用法 Active JP7744248B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962869435P 2019-07-01 2019-07-01
US62/869,435 2019-07-01
PCT/US2020/040282 WO2021003149A1 (en) 2019-07-01 2020-06-30 Transgenic mammals and methods of use

Publications (4)

Publication Number Publication Date
JP2022538886A JP2022538886A (ja) 2022-09-06
JP2022538886A5 true JP2022538886A5 (https=) 2023-07-07
JPWO2021003149A5 JPWO2021003149A5 (https=) 2023-07-07
JP7744248B2 JP7744248B2 (ja) 2025-09-25

Family

ID=71784658

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577915A Active JP7744248B2 (ja) 2019-07-01 2020-06-30 トランスジェニック哺乳動物およびその使用法

Country Status (8)

Country Link
US (1) US20210000087A1 (https=)
EP (1) EP3993622A1 (https=)
JP (1) JP7744248B2 (https=)
CN (1) CN114502725B (https=)
AU (1) AU2020299569A1 (https=)
CA (1) CA3144956A1 (https=)
IL (1) IL289473A (https=)
WO (1) WO2021003149A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022268937A1 (en) * 2021-05-05 2023-10-26 Trianni, Inc. Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereof
GB202107372D0 (en) 2021-05-24 2021-07-07 Petmedix Ltd Animal models and therapeutics molecules
EP4408981A1 (en) 2021-10-01 2024-08-07 AbCellera Biologics Inc. Transgenic rodents for cell line identification and enrichment
IL312359A (en) * 2021-11-10 2024-06-01 Trianni Inc Transgenic mammals and methods of use thereof
GB202209247D0 (en) 2022-06-23 2022-08-10 Petmedix Ltd Animal models and therapeutic molecules
GB202217978D0 (en) * 2022-11-30 2023-01-11 Petmedix Ltd Rodents expressing a common light chain

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
GB8904009D0 (en) 1989-02-22 1989-04-05 Celltech Ltd Vector
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US6689610B1 (en) 1989-08-22 2004-02-10 University Of Utah Research Foundation Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US7041871B1 (en) 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
ATE352612T1 (de) 1990-08-29 2007-02-15 Pharming Intellectual Pty Bv Homologe rekombination in säugetier-zellen
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5789650A (en) 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
DE4228162C1 (de) 1992-08-25 1994-01-13 Rajewsky Klaus Dr Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern
US5593598A (en) 1994-04-20 1997-01-14 Mcginness; Michael P. Method and apparatus for closed loop recycling of contaminated cleaning solution
US6091001A (en) 1995-03-29 2000-07-18 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
EP1500329B1 (en) 1996-12-03 2012-03-21 Amgen Fremont Inc. Human antibodies that specifically bind human TNF alpha
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7422889B2 (en) 2004-10-29 2008-09-09 Stowers Institute For Medical Research Dre recombinase and recombinase systems employing Dre recombinase
PL3456190T3 (pl) * 2008-06-27 2022-06-06 Merus N.V. Wytwarzające przeciwciała transgeniczne zwierzę z gatunku myszy
US9445581B2 (en) * 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
JP6482757B2 (ja) * 2010-07-26 2019-03-13 トリアンニ インコーポレイテッドTrianni,Inc. トランスジェニック動物および使用方法
US10662256B2 (en) * 2010-07-26 2020-05-26 Trianni, Inc. Transgenic mammals and methods of use thereof
US9253965B2 (en) * 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
GB2561352B (en) * 2017-04-10 2023-01-18 Genome Res Ltd Animal models and therapeutic molecules
DK4140297T3 (da) * 2017-12-05 2025-06-23 Regeneron Pharma Mus med en konstrueret immunglobulin-lambda-letkæde og anvendelser deraf
GB2578867A (en) * 2018-10-09 2020-06-03 Genome Res Ltd Animal models and therapeutic molecules

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2022538886A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)